<code id='E3332B75F1'></code><style id='E3332B75F1'></style>
    • <acronym id='E3332B75F1'></acronym>
      <center id='E3332B75F1'><center id='E3332B75F1'><tfoot id='E3332B75F1'></tfoot></center><abbr id='E3332B75F1'><dir id='E3332B75F1'><tfoot id='E3332B75F1'></tfoot><noframes id='E3332B75F1'>

    • <optgroup id='E3332B75F1'><strike id='E3332B75F1'><sup id='E3332B75F1'></sup></strike><code id='E3332B75F1'></code></optgroup>
        1. <b id='E3332B75F1'><label id='E3332B75F1'><select id='E3332B75F1'><dt id='E3332B75F1'><span id='E3332B75F1'></span></dt></select></label></b><u id='E3332B75F1'></u>
          <i id='E3332B75F1'><strike id='E3332B75F1'><tt id='E3332B75F1'><pre id='E3332B75F1'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:12
          the shape of a medical note connected by dots and lines — health tech coverage from STAT
          Adobe

          In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

          But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

          advertisement

          This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more
          Surge in Apellis stock fueled by confidence in safety of its eye drug
          Surge in Apellis stock fueled by confidence in safety of its eye drug

          MollyFerguson/STATSharesofApellisPharmaceuticalsarerebounding,drivenbyagrowingbeliefamongsomeinvesto

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          Indictment alleges Trump's ex

          4:11ChiefofstaffMarkMeadowslistensasPresidentDonaldTrumpspeaksintheOvalOfficeoftheWhiteHouseonSept.1